Cargando…
The effect of azithromycin for management of HIV-associated chronic lung disease on right heart function: Results from the BREATHE trial
BACKGROUND: Right heart abnormalities and pulmonary hypertension (PH) may be secondary to chronic lung disease. Chronic lung disease is common in children with HIV. In the BREATHE trial (Trial registration: NCT02426112), azithromycin (AZM) reduced the risk of acute respiratory exacerbations in child...
Autores principales: | Majonga, Edith D., Mapurisa, Gugulethu Newton, Rehman, Andrea M., McHugh, Grace, Bandason, Tsitsi, Mujuru, Hilda, Gonzalez-Martinez, Carmen, Odland, Jon O., Kennedy, Neil, Ferrand, Rashida A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609135/ https://www.ncbi.nlm.nih.gov/pubmed/34849393 http://dx.doi.org/10.1016/j.ijcha.2021.100920 |
Ejemplares similares
-
Effect of azithromycin on incidence of acute respiratory exacerbations in children with HIV taking antiretroviral therapy and co-morbid chronic lung disease: a secondary analysis of the BREATHE trial
por: Price, Amy, et al.
Publicado: (2021) -
False-negative HIV tests using oral fluid tests in children taking antiretroviral therapy from Harare, Zimbabwe
por: Olaru, Ioana D., et al.
Publicado: (2017) -
Effect of Once-Weekly Azithromycin vs Placebo in Children With HIV-Associated Chronic Lung Disease: The BREATHE Randomized Clinical Trial
por: Ferrand, Rashida A., et al.
Publicado: (2020) -
Adherence to additional medication for management of HIV-associated comorbidities among older children and adolescents taking antiretroviral therapy
por: Rehman, Andrea M., et al.
Publicado: (2022) -
Carotid intima media thickness in older children and adolescents with HIV taking antiretroviral therapy
por: Majonga, Edith D., et al.
Publicado: (2020)